Skip to main content
. 2020 Jul 31;10(7):e038302. doi: 10.1136/bmjopen-2020-038302

Table 1.

Clinical, angiographic and procedural characteristics

Variables Overall (n=1987) <15 mm (n=957) ≥15 mm (n=1030) P value
Clinical characteristics
 Age, years 57.1±10.5 58.0±10.3 56.3±10.6 <0.001
 Female, % 344 (17.3) 189 (19.7) 155 (15.0) 0.006
 Prior MI, n (%) 980 (49.3) 460 (48.1) 520 (50.5) 0.281
 Prior PCI, n (%) 179 (9.0) 72 (7.5) 107 (10.4) 0.025
 Prior CABG, n (%) 63 (3.2) 26 (2.7) 37 (3.6) 0.264
 Prior stroke, n (%) 149 (7.5) 63 (6.6) 86 (8.3) 0.134
 Current smoking, n (%) 790 (39.8) 355 (37.1) 435 (42.2) 0.04
 Hypertension, n (%) 1267 (63.8) 636 (66.5) 631 (61.3) 0.016
 Hyperlipidemia, n (%) 1677 (48.4) 793 (82.9) 884 (85.8) 0.069
 Diabetes mellitus, n (%) 612 (30.8) 290 (30.3) 322 (31.3) 0.643
 Family history of CAD, n (%) 235 (11.8) 102 (10.7) 133 (12.9) 0.119
 BMI, kg/m2 26.5±3.3 26.3±3.2 26.6±3.4 0.09
 Stable angina, n (%) 1087 (54.7) 515 (53.8) 572 (55.5) 0.442
 LVEF, % 60.4±8.3 60.7±8.0 60.2±8.6 0.175
 eGFR, mL/min/1.73 m2 100.7±28.8 98.9±27.9 102.2±29.6 0.023
 PAD, n (%) 90 (4.5) 38 (4.0) 52 (5.0) 0.247
Angiographic characteristics
 LAD CTO, n (%) 827 (41.6) 404 (41.2) 423 (39.2) 0.341
 LCX CTO, n (%) 316 (15.9) 172 (17.6) 144 (13.3) 0.008
 RCA CTO, n (%) 913 (45.9) 400 (40.8) 513 (47.5) 0.002
 Previous attempt, n (%) 48 (2.3) 17 (1.7) 31 (2.9) 0.085
 Calcification, n (%) 172 (8.3) 71 (7.2) 101 (9.4) 0.083
 Bending, n (%) 158 (7.7) 24 (2.4) 134 (12.4) <0.001
 Blunt stump, n (%) 128 (6.2) 51 (5.2) 77 (7.1) 0.069
 J-CTO score 1.4±1.0 0.8±0.7 1.8±1.0 <0.001
 SYNTAX score 19.2±8.4 19.6±8.2 18.9±8.6 0.088
Procedural characteristics
 Previous attempt, n (%) 48 (2.3) 17 (1.7) 31 (2.9) 0.085
 Retrograde approach, n (%) 37 (1.8) 4 (0.4) 33 (3.1) <0.001
 Use of DES, n (%) 1390 (70.0) 674 (70.4) 716 (69.5) 0.657
 Contrast volume, mL 182.8±119.7 179.4±115.2 186.0±123.0 0.241

All values are shown as number (%) or mean±SD. Bold values are statistically significant (p<0.05).

BMI, body mass index; CABG, coronary artery bypass grafting; CAD, coronary artery disease; CTO, chronic total occlusion; DES, drug eluted stent; eGFR, estimated glomerular filtration rate; J-CTO, multicenter CTO registry of Japan; LAD, left anterior descending artery; LCX, left circumflex artery; LVEF, left ventricular ejection fraction; MI, myocardial infarction; PAD, peripheral artery disease; PCI, percutaneous coronary intervention; RCA, right coronary artery; SYNTAX, synergy between percutaneous coronary intervention with taxus and cardiac surgery.